IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 372 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,602,000 | +19.2% | 63,707 | 0.0% | 0.88% | -1.3% |
| Q3 2020 | $3,023,000 | -19.5% | 63,707 | 0.0% | 0.90% | -28.5% |
| Q2 2020 | $3,756,000 | +9.9% | 63,707 | -11.8% | 1.25% | -12.6% |
| Q1 2020 | $3,417,000 | -16.1% | 72,267 | +7.2% | 1.44% | +0.1% |
| Q4 2019 | $4,074,000 | +10.5% | 67,433 | +8.0% | 1.43% | +2.1% |
| Q3 2019 | $3,688,000 | +138.9% | 62,434 | +161.6% | 1.40% | +148.2% |
| Q2 2019 | $1,544,000 | +25.9% | 23,866 | 0.0% | 0.57% | +4.2% |
| Q1 2019 | $1,226,000 | 0.0% | 23,866 | 0.0% | 0.54% | +3.6% |
| Q4 2018 | $1,226,000 | -0.7% | 23,866 | 0.0% | 0.52% | +23.6% |
| Q3 2018 | $1,235,000 | +23.3% | 23,866 | 0.0% | 0.42% | +14.3% |
| Q2 2018 | $1,002,000 | -4.8% | 23,866 | 0.0% | 0.37% | -14.3% |
| Q1 2018 | $1,052,000 | – | 23,866 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |